Nephrocare Health Services Limited IPO | Important Dates, Price, and More
Nephrocare Health Services Limited is launching an ₹871.05 crore IPO, opening for subscription on December 10, 2025. The IPO will close on December 12, 2025. The shares will be listed on BSE and NSE, with a tentative listing date of December 17, 2025.
The price band is set at ₹438 – ₹460 per share, and the minimum lot size is 32 shares. For retail investors, the minimum investment is ₹14,720 (32 shares) at the upper band. In comparison, sNII investors must apply for 448 shares (₹2,06,080), while bNII investors must apply for 2,176 shares (₹10,00,960).
The Nephrocare Health IPO includes a fresh issue of 0.77 crore shares worth ₹353.40 crore and an offer for sale (OFS) of 1.13 crore shares worth ₹517.64 crore. The issue also includes an employee reservation, with eligible employees receiving a discount of ₹41 per share.
Here are the quick steps to apply for the Nephrocare Health Services Limited IPO!
Nephrocare Health Services Limited | IPO Details
| Detail | Information |
| IPO Opening Date | December 10, 2025 |
| IPO Closing Date | December 12, 2025 |
| Tentative IPO Listing Date | December 17, 2025 |
| Face Value | ₹2 per share |
| Price Band | ₹438 – ₹460 per share |
| Lot Size | 32 shares |
| Total Issue Size | 1,89,35,819 shares (₹871.05 Cr) |
| Fresh Issue | 76,82,717 shares (₹353.40 Cr) |
| Offer for Sale (OFS) | 1,12,53,102 shares (₹517.64 Cr) |
| Employee Discount | ₹41 per share |
| IPO Segment | Main Board – Book Building |
| Listing At | BSE, NSE |
| Registrar | KFin Technologies Ltd. |
| Shareholding Pre-Issue | 9,26,50,799 shares |
| Shareholding Post-Issue | 10,03,33,516 shares |
Nephrocare Health Services Limited | Company Overview
Nephrocare Health Services Limited is a multi-speciality healthcare provider focused on offering advanced nephrology care, dialysis services, and chronic kidney disease (CKD) management. The company provides integrated services, including nephrology consultation, hemodialysis, ICU support, transplantation evaluation, and diagnostic services.
The company follows a patient-centric model backed by clinical expertise, modern medical infrastructure, and standardised treatment protocols. Over the years, Nephrocare has expanded its operational capacity, strengthened its clinical team, and invested in advanced technology to support kidney care and chronic disease management.
Don’t miss the chance to invest in the Nephrocare Health Services IPO. Open a free Demat account today!
Nephrocare Health Services Limited IPO | Key Details
- IPO Opening Date: December 10, 2025
- IPO Closing Date: December 12, 2025
- Allotment Date: December 15, 2025
- Price Band: ₹438 – ₹460 per share
- IPO Size: ₹871.05 Crores (Fresh Issue + OFS)
- Refunds Initiated: December 16, 2025
- Shares Credited to Demat: December 16, 2025
- Listing Date: December 17, 2025
- Cut-off Time for UPI Mandate Confirmation: 5 PM on December 12, 2025
Nephrocare Health Services Limited IPO | Financial Overview
Nephrocare Health Services Ltd. reported strong financial growth, recording a 34% increase in revenue and a 91% rise in PAT between FY24 and FY25.
Here’s a snapshot of its year-on-year financial performance:
Amounts are in ₹ Crore
| Detail | 31-Mar-25 | 31-Mar-24 | Change | Change % |
| Assets | 996.46 | 806.02 | +190.44 | +23.64% |
| Total Income | 769.92 | 574.72 | +195.20 | +33.97% |
| Profit After Tax | 67.10 | 35.13 | +31.97 | +91.02% |
| EBITDA | 166.64 | 99.66 | +66.98 | +67.17% |
| Net Worth | 594.21 | 423.55 | +170.66 | +40.28% |
| Reserves & Surplus | 578.68 | 408.57 | +170.11 | +41.63% |
| Total Borrowing | 225.80 | 243.37 | -17.57 | -7.22% |
Nephrocare Health Services Limited IPO | FAQs
The Nephrocare Health IPO opens on December 10, 2025, and closes on December 12, 2025.
The Nephrocare Health IPO price band is ₹438 – ₹460 per share, and the Nephrocare Health IPO lot size is 32 shares.
You can check the Nephrocare Health IPO allotment status on the registrar’s website, KFin Technologies Ltd., using your PAN, DP ID, or application number.
The registrar for the Nephrocare Health IPO is KFin Technologies Ltd.
The Nephrocare Health IPO face value is ₹2 per share, which is the nominal share value used for IPO valuation and share classification.
The Nephrocare Health IPO offers a total of 1.89 crore shares, including 0.77 crore fresh shares and 1.13 crore shares offered through OFS.
Source: https://www.nseindia.com/
Disclaimer: Investments in the securities market are subject to market risks; read all the related documents carefully before investing.